Biofrontera
Woburn
About Biofrontera
Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics. The company's licensed products focus on the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Biofrontera was founded in 2015 and is headquartered in Woburn, Massachusetts, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $25.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: nasdaq:BFRI
- Website: biofrontera-us.com
- Phone: 781-245-1325
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biofrontera-31617 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.